Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Dividend Declaration

13 Feb 2020 07:30

RNS Number : 8305C
Aberdeen Emerging Markets Inv Co Ld
13 February 2020
 

12 February 2020

 

ABERDEEN EMERGING MARKETS INVESTMENT COMPANY LIMITED (the "Company")

Legal Entity Identifier (LEI): 213800RIA1NX8DP4P938

 

First interim dividend

As per the Company's final results announcement published earlier today, the Board has declared a first interim dividend for the year ending 31 October 2020 of 5.5p per ordinary share.

The following dates will be applicable to the dividend:

Ex-dividend date - 27 February 2020

 

Record date - 28 February 2020

 

Payment date - 27 March 2020

 

 

 

Enquiries:

Aberdeen Standard Fund Managers Limited (Alternative Investment Fund Manager to Aberdeen Emerging Markets Investment Company Limited)

William Hemmings

Tel: +44 (0)207 463 5881

 

PraxisIFM Fund Services (UK) Limited (UK Administration Agent)

Brian Smith Tel: +44 (0)20 7653 9690

 

Ordinary Shares - Listing Category: Premium - Equity Closed-ended Investment Funds

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DIVTTMPTMTMBBRM

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.